Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Cochlear Limited    COH   AU000000COH5

COCHLEAR LIMITED

(COH)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Cochlear Ltd is an Australia-based company that provides implantable hearing solutions. The Company provides bone conduction implants for people with conductive hearing loss, mixed hearing loss and single-sided deafness. Its segments include Americas, EMEA and Asia Pacific. Americas includes the United States, Canada and Latin America. EMEA includes Europe, Middle East and Africa. Asia Pacific includes Australasia and Asia. Its implantable hearing solution portfolio includes Cochlear implants, such as Cochlear Nucleus Profile Plus with Slim Modiolar Electrode (CI632), Cochlear Nucleus Kanso Sound Processor (CP950), Cochlear Nucleus 7 Sound Processor (CP1000) and Cochlear Nucleus smart application and bone conduction implants, such as Cochlear Baha 5, Baha 5 Power and Baha 5 SuperPower, Cochlear Baha SoundArc, Cochlear Baha Smart App and Cochlear Carina System.

Number of employees : 4 000 people.
Sales per Business
20192020Delta
AUD (in Million)%AUD (in Million)%
Cochlear Implants845.1058.4%817.9060.5% -3.22%
Services (Sound Processor Upgrades and Other)427.2029.5%395.5029.2% -7.42%
Acoustics (Bone Conduction and Acoustic Implants)173.8012%138.9010.3% -20.08%
Sales per region
20192020Delta
AUD (in Million)%AUD (in Million)%
Americas688.6047.6%650.3048.1% -5.56%
EMEA519.2035.9%479.6035.5% -7.63%
Asia Pacific238.3016.5%222.4016.4% -6.67%
Managers and Directors
NameAgeSinceTitle
Diggory Howitt-2018President, CEO, Executive Director & MD
Roderick Holliday-Smith702010Chairman
Stuart Sayers-2021Chief Financial Officer & President-Services
Jan Janssen552017Chief Technology Officer
David Hackshall-2015Chief Information Officer
Andrew Leslie Denver712007Independent Non-Executive Director
Yasmin Anita Allen562010Independent Non-Executive Director
Glen F. Boreham562015Independent Non-Executive Director
Catriona Deans522015Independent Non-Executive Director
Bruce G. Robinson, Dr.632016Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 65,687,402 65,310,888 99.4% 0 0.0% 99.4%
Shareholders
NameEquities%
Baillie Gifford & Co. 3,944,356 6.00%
Veritas Asset Management LLP 3,696,542 5.62%
BlackRock Fund Advisors 2,107,228 3.21%
The Vanguard Group, Inc. 1,732,447 2.64%
Norges Bank Investment Management 973,764 1.48%
Vanguard Investments Australia Ltd. 738,049 1.12%
Aberdeen Standard Investments (Asia) Ltd. 709,897 1.08%
Invesco Advisers, Inc. 663,499 1.01%
Franklin Templeton Institutional LLC 628,266 0.96%
BlackRock Investment Management (Australia) Ltd. 607,517 0.92%
Holdings
NameEquities%Valuation
Sensorion (ALSEN) 644,9450.84%1,064,649 USD
Company contact information
Cochlear Ltd.
1 University Avenue
Macquarie University
Sydney, New South Wales (NSW) 2109

Phone : +61.2.9428.6555
Fax : +61.2.9428.6353
Web : http://www.cochlear.com
Sector Medical Equipment, Supplies & Distribution
1st jan.Capitalization (M$)
COCHLEAR LIMITED-0.11%9 682
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
STRYKER CORPORATION-1.24%90 938
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.24%50 041
ALIGN TECHNOLOGY, INC.6.15%44 726
IDEXX LABORATORIES, INC.-2.08%41 751
BAXTER INTERNATIONAL INC.-0.25%40 886
ALCON INC.5.95%34 771
SARTORIUS STEDIM BIOTECH6.46%34 549
DEXCOM, INC.-4.20%34 013
ZIMMER BIOMET HOLDINGS3.91%33 189
COLOPLAST A/S-4.30%30 861
TERUMO CORPORATION-4.06%30 113
SYSMEX CORPORATION3.63%25 867
WEST PHARMACEUTICAL SERVICES, INC.5.44%22 135
AMERISOURCEBERGEN CORPORATION9.25%21 861
10X GENOMICS, INC.26.89%19 334
SMITH & NEPHEW PLC4.44%18 762
INSULET CORPORATION10.00%18 539